OBParp 150mg 8 TABLETS

Form: Tablet

Pack Size: 8 Tablets

Marketed by: CIPLA LTD (CANCER CARE)

MRP: ₹2208.93

Obparp 150mg by Cipla (olaparib 150 mg, 8 tablets) is a PARP inhibitor (targeted therapy) listed under Cancer Care (Oncology) on WholesaleChemist for distributors, hospital pharmacies and retail chemists. Prescribed by oncologists for BRCA-mutated ovarian cancer as maintenance treatment, BRCA-mutated HER2-negative breast cancer, prostate cancer with DNA-repair gene mutations and BRCA-mutated pancreatic cancer. Schedule H: dispense only against a valid prescription. Counselling point: anaemia and nausea are common; monitor blood counts.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.